
Client Alert
01/09/2023
Procedure changes for prioritizing registration, post-registration, and prior consent for clinical research of medicines come into force
Published on August 21, Anvisa’s RDC No. 811/2023 comes into force today (September 1, 2023). The new resolution changed the following rules: Anvisa’s RDC No. 204/2017, which sets out the priority category for applications for registration, post-registration, and prior consent for clinical research of medicines; and Anvisa’s RDC No. 205/2017, which establishes a special procedure …


